Alternate Day Buprenorphine Administration, Phase IX
Alternate Day Buprenorphine Administration, Phase IX
The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.
Please contact site for information.